ASP Isotopes (NASDAQ:ASPI) COO Sells $117,225.00 in Stock

ASP Isotopes Inc. (NASDAQ:ASPI) COO Robert Ainscow sold 22,500 shares of the business’s stock in a transaction dated Thursday, April 16th. The shares were sold at an average price of $5.21, for a total value of $117,225.00. Following the completion of the transaction, the chief operating officer owned 1,490,317 shares in the company, valued at $7,764,551.57. This trade represents a 1.49% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Ainscow also recently made the following trade(s):

• On Friday, March 6th, Robert Ainscow sold 25,000 shares of ASP Isotopes stock. The shares were sold at an average price of $4.51, for a total value of $112,750.00.
• On Friday, March 6th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The shares were sold at an average price of $5.44, for a total value of $45,902.72.

ASP Isotopes Stock Performance

Shares of NASDAQ ASPI opened at $5.37 on Monday. The business’s 50-day moving average price is $5.06 and its two-hundred day moving average price is $6.70. The company has a debt-to-equity ratio of 0.77, a current ratio of 12.23 and a quick ratio of 12.20. ASP Isotopes Inc. has a one year low of $3.92 and a one year high of $14.49. The company has a market capitalization of $676.08 million, a P/E ratio of -2.51 and a beta of 3.59.

ASP Isotopes (NASDAQ:ASPI) last issued its earnings results on Friday, April 10th. The company reported ($0.84) EPS for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.70). ASP Isotopes had a negative net margin of 734.14% and a negative return on equity of 161.55%. The firm had revenue of $33.32 million during the quarter, compared to analysts’ expectations of $2.03 million. Analysts anticipate that ASP Isotopes Inc. will post -0.24 earnings per share for the current fiscal year.

Institutional Trading of ASP Isotopes

Institutional investors and hedge funds have recently made changes to their positions in the stock. Quantbot Technologies LP acquired a new stake in shares of ASP Isotopes in the third quarter worth about $34,000. BNP Paribas Financial Markets lifted its position in shares of ASP Isotopes by 84.9% in the second quarter. BNP Paribas Financial Markets now owns 5,549 shares of the company’s stock worth $41,000 after buying an additional 2,548 shares during the last quarter. Close Asset Management Ltd acquired a new stake in shares of ASP Isotopes in the third quarter worth about $72,000. Legal & General Group Plc lifted its position in shares of ASP Isotopes by 30.4% in the third quarter. Legal & General Group Plc now owns 8,377 shares of the company’s stock worth $81,000 after buying an additional 1,953 shares during the last quarter. Finally, IFP Advisors Inc acquired a new position in shares of ASP Isotopes during the 4th quarter worth about $48,000. Institutional investors and hedge funds own 16.80% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on ASPI shares. Canaccord Genuity Group reaffirmed a “buy” rating and issued a $11.00 price target on shares of ASP Isotopes in a research report on Tuesday, April 14th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research report on Friday, March 27th. Two analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $13.00.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.